December 14, 2010
During the last quarter of 2010 we represented an Israeli public biotech company, traded on the Tel Aviv Stock Exchange, in a 12 million dollar private offering of its securities acquired by a leading agro business multi-national.
December 14, 2010
During the last quarter of 2010 we represented an Israeli public biotech company, traded on the Tel Aviv Stock Exchange, in a 12 million dollar private offering of its securities acquired by a leading agro business multi-national.